Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Clinical Trial of Genexol -PM in Patients With Advanced Pancreatic Cancer

NCT00111904 is registered in ClinicalTrials.gov with Theradex as lead sponsor.

NCT NCT00111904
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00111904 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Clinical Trial of Genexol -PM in Patients With Advanced Pancreatic Cancer
Lead sponsor
Theradex
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2005
Completion date
Not reported
Enrollment
43 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer